Business
AstraZeneca US COVID-19 vaccine trial may resume as soon as this week – Sydney Morning Herald
The pharma giant’s coronavirus vaccine trial in the United States is expected to resume as early as this week after the US Food and Drug Administration completed…
In a research and development briefing held for CSL investors on Tuesday, the company’s chief scientific officer Dr Andrew Nash said preparations to produce both vaccines were moving along well and production of the AstraZeneca product could start early next year.
He said the AstraZeneca/Oxford and University of Queensland projects used different approaches, with UQ’s being a more “classical” vaccine model while AstraZeneca’s was a newer approach, and it was a positive that both projects could be…
-
General19 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General24 hours agoOlder Aussies back increased superannuation tax
-
Noosa News21 hours agoTips to improve engagement – Proctor
-
Noosa News21 hours agoPolice appeal for information over suspected link in torture and murder cases